Skip to content

EFFECTS OF CALIBRATED BLUE–YELLOW CHANGES IN LIGHT ON THE HUMAN CIRCADIAN CLOCK - A RANDOMISED CONTROLLED CLINICAL STUDY

EFFECTS OF CALIBRATED BLUE–YELLOW CHANGES IN LIGHT ON THE HUMAN CIRCADIAN CLOCK - A RANDOMISED CONTROLLED CLINICAL STUDY - Twilight

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023603
Enrollment
16
Registered
2020-11-17
Start date
2021-11-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

Group 1: Constant "background" light profile of photoreceptor activation matched to daylight at 6500K (used during first experimental visit) Group 2: Sinusoidally flickering (1Hz) light with low stimu
+37% L+M cone contrast from background). Group 3: Sinusoidally flickering (1Hz) light with higher stimulation of S-cones, but decreased brightness (blue-dim: +37% S-cone contrast, –37% L+M contrast fr

Sponsors

FWF Wissenschaftsfonds
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: • Age: 18-35 years • Body Mass Index: 18.5-24.9 (i.e. normal weight according to WHO criteria) • Informed consent as documented by signature of the participant

Exclusion criteria

Exclusion criteria: • Previous enrollment in the study’s project part • Investigator’s family members, employees or other dependent persons • Self-reported photosensitive epilepsy • Pregnancy • Chronic or debilitating medical conditions • Drug use • Abnormal colour vision as established in the Cambridge Colour Test • Shift work 2 time zones) < 1 month prior to beginning of the study • Extreme chronotype • Short and long sleep duration (subjective sleep duration on workdays outside 6-10h according to the MCTQ) • Inability to understand and/or follow procedures • Non-adherence to sleep/wake times during the ambulatory part (i.e. protocol for the stabilization of the sleep-wake cycle

Design outcomes

Primary

MeasureTime frame
Phase shift, i.e. difference in DLMO between the first evening of each experimental visit and the second evening.

Secondary

MeasureTime frame
• The time course (t1, t2, …tn) of visual comfort ratings • The time course (t1, t2, …tn) of median reaction time, 10% fastest reaction times, 10% slowest reaction times • EEG-derived sleep onset latency • EEG-redived slow wave activity (SWA) during the first sleep cycle

Countries

Switzerland

Contacts

Public ContactChristine Blume

Universität Basel

christine.blume@upk.ch00491704154909

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026